Results 151 to 160 of about 4,209 (214)

Antenatal Steroids and Tocolytics in Pregnancy

Obstetrics and Gynecology Clinics of North America, 2023
Preterm birth, typically defined as birth between 20 0/7 weeks and 36 6/7 weeks of gestation, is a major cause of neonatal morbidity, and rates of preterm birth continue to rise. Antenatal corticosteroids have demonstrated benefit for reduction of morbidities and mortality associated with preterm birth, with few observed maternal risks.
Kelsey, Pinson, Cynthia, Gyamfi-Bannerman   +1 more
openaire   +2 more sources

Tocolytic Drugs

2023
Abstract Tocolytic agents are agents that inhibit uterine contraction and allow enough time for corticosteroids to help with lung maturation. They are administered in cases of premature labor between the 22nd and 34th weeks of gestational age.
Piotr Al-Jindi, Bethany Potere
openaire   +1 more source

Effect of tocolytic drugs on fetal heart rate variability: a systematic review

Journal of Maternal-Fetal and Neonatal Medicine, 2017
Introduction: Tocolytics may cause changes in fetal heart rate (HR) pattern, while fetal heart rate variability (HRV) is an important marker of fetal well-being.
Judith O.E.H. van Laar, Alexandra D J Hulsenboom, S Guid Oei   +2 more
exaly   +2 more sources

Uterotonics and tocolytics for anesthesiologists

Current Opinion in Anaesthesiology, 2016
Obstetric anesthesiologists are supposed to understand the uterotonics and tocolytics used in the perinatal period to provide a better clinical practice. This review describes current consensus of uterotonics and tocolytics used in the perinatal period that an obstetric anesthesiologist should know.Rational use of uterotonics for cesarean section has ...
Hiroyuki, Sumikura, Eiichi, Inada
openaire   +2 more sources

Pharmacokinetics of Tocolytic Agents

Clinical Pharmacokinetics, 2004
Tocolytic agents are drugs designed to inhibit contractions of myometrial smooth muscle cells. Such an effect has been demonstrated in vitro or in vivo for several pharmacological agents, including beta-adrenergic agonists, calcium channel antagonists, oxytocin antagonists, NSAIDs and magnesium sulfate. However, the aim of tocolysis is not only to stop
Vassilis, Tsatsaris, Dominique, Cabrol, Bruno, Carbonne   +2 more
openaire   +2 more sources

Controversies in Tocolytic Therapy

Clinical Obstetrics and Gynecology, 1999
In general, tocolytic agents are effective in stopping uterine contractions and in temporarily delaying delivery. The benefit of stopping uterine contractions is dependent on the fetal status and gestational age. The rationale for stopping preterm labor is to improve neonatal outcome.
V L, Katz, R M, Farmer
openaire   +2 more sources

Pharmacology of Tocolytic Agents

Clinics in Obstetrics and Gynaecology, 1984
Various drugs have been used to inhibit preterm labour. Selective beta-receptor agonists are the drugs of choice and have been extensively studied for more than ten years. Several controlled studies have demonstrated a significant prolongation of the pregnancy after treatment with beta-receptor agonists and some have demonstrated improved fetal outcome.
openaire   +2 more sources

Tocolytics in obstetric practice

Journal of obstetrics and women's diseases, 2023
Preterm birth remains a leading cause of perinatal mortality and morbidity in preterm infants and leads to significant annual health care costs. A special role in preventing premature birth belongs to tocolytic therapy, which allows for prolonging pregnancy and avoiding various complications.
Aydar M. Ziganshin, Elena V. Akbulatova
openaire   +1 more source

Update on Tocolytic Therapy

Annals of Pharmacotherapy, 1995
Objective: To review medications currently being used or investigated for the treatment of preterm labor. Adverse effects, pharmacoeconomic issues, and therapeutic controversies are included. Data Sources: A MEDLINE search, limited to ...
openaire   +2 more sources

Magnesium sulfate as a tocolytic agent

Seminars in Perinatology, 2001
Although magnesium sulfate is widely used as a tocolytic agent in the hope of preventing spontaneous preterm birth, there is a paucity of data from large well-designed randomized clinical studies demonstrating the efficacy of magnesium sulfate therapy. Given the potential for untoward side effects and the inherent risks of magnesium sulfate therapy, a ...
P S, Ramsey, D J, Rouse
openaire   +2 more sources